Naltiazem
Naltiazem (Ro 23-6152) is a thiazepinone-type calcium antagonist. Naltiazem inhibits platelet aggregation in vitro and in vivo[1].
Product Specifications
CAS Number
108383-95-5
Product Name Alternative
Ro 23-6152
UNSPSC
12352005
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/naltiazem.html
Smiles
CN(C)CCN1C2=CC=C(C=CC=C3)C3=C2S[C@@H](C4=CC=C(C=C4)OC)[C@H](C1=O)OC(C)=O
Molecular Formula
C26H28N2O4S
Molecular Weight
464.58
References & Citations
[1]L A Sordahl, et al. In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152) . J Cardiovasc Pharmacol. 1991 Oct;18 (4) :504-10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR207218L3 10 µg
Lenti ORF clone of Txnrd1 (Myc-DDK-tagged) - Mouse thioredoxin reductase 1 (Txnrd1), transcript variant 4, (Note: selenocysteine protein, Interna
Sign In for Pricing
View Details K0904907 1.0 µg DNA
GREM2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details